ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES RECURRENT

This adverse event was reported 28 times

ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PRALATREXATE 1 0.0015
1 BRENTUXIMAB VEDOTIN 15 0.0014
2 HYDROCORTISONE SODIUM SUCCINATE 3 0.0008
3 ROMIDEPSIN 1 0.0006
4 BRIGATINIB 1 0.0003
5 FOSCARNET SODIUM 1 0.0002
6 CRIZOTINIB 3 0.0002
7 DOXORUBICIN HYDROCHLORIDE 7 0.0002
8 DOXORUBICIN 19 0.0002
9 IFOSFAMIDE FOR INJECTION 3 0.0001
See all drugs enriched for association with ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES RECURRENT